National Coastal Safety Report is an important reminder for everyone to be alert and cautious in the water this summer

The Turnbull Government is today launching Surf Life Saving Australia’s 2017 National Coastal Safety Report – which found that 116 people died from drowning around the Australian coastline in 2016-17.  While this was down from the previous year, it was 10.5 per cent higher than 2014-15.  It’s a timely reminder for swimmers of all abilities…

New national plasma agreement ensures supply for Australian patients

The Federal Coalition Government has guaranteed the provision of a safe, secure and affordable supply of plasma products and services with the signing of an important new agreement. The National Blood Authority has executed a new national contract with CSL Behring Australia for the manufacture and supply of fractionated blood plasma products. Plasma products are…

Time for action on endometriosis

The Turnbull Government will create the first National Action Plan for Endometriosis, providing much needed support for women who face this often misunderstood medical condition.  The Plan will seek to improve the treatment, understanding and awareness of endometriosis, which affects around one in ten Australian women.  It will be developed in collaboration with the Australian…

Major $640 million investment in Australia’s world-leading medical research

The Turnbull Government will invest $640 million to support Australia’s world-leading health and medical researchers as they continue their work in the laboratory, clinic and the community to find the next major medical breakthrough. Cancer research continues to be a major priority for the Turnbull Government with $109 million allocated to projects for research into…

Continuing to make new medicines affordable for Australians

A new medicine to treat soft tissue sarcoma will be available through the Pharmaceutical Benefits Scheme (PBS) from today, giving more than 100 Australians a year access to affordable life-improving treatment. Eribulin (Halaven®) provides eligible patients with an alternative treatment to currently listed medicines.  It works by inhibiting the growth of cancer cells. The independent…